Triisopropyl borate → (2-(N-(tert-Butyl)sulfamoyl)-5-isobutylthiophen-3-yl)boronic acid

HRID 1807815Notes

Reaction equation

HRID 1807815 reaction equation
[CH2:1]([C:5]1[S:9][C:8]([S:10]([NH:13][C:14]([CH3:17])([CH3:16])[CH3:15])(=[O:12])=[O:11])=[CH:7][CH:6]=1)[CH:2]([CH3:4])[CH3:3].[Li]CCCC.C([O:26][B:27](OC(C)C)[O:28]C(C)C)(C)C>C1COCC1>[CH2:1]([C:5]1[S:9][C:8]([S:10]([NH:13][C:14]([CH3:15])([CH3:17])[CH3:16])(=[O:12])=[O:11])=[C:7]([B:27]([OH:28])[OH:26])[CH:6]=1)[CH:2]([CH3:4])[CH3:3]

Participants

5

Conditions

Temperature
-20 °C

Procedure

5-iso-Butyl-N-tert-butylthiophene-2-sulfonamide (10.6 g, 0.039 mol, see step (b) above) was dissolved in THF (165 mL) under N2 and then cooled to −78° C. n-BuLi (1.6 M, 60.19 mL, 0.096 mol) was added via a syringe. The reaction mixture was stirred at −20° C. for 4 h. Tri-iso-propylborate (13.3 mL, 0.058 mol) was then added via a syringe and the reaction mixture was stirred overnight at room temperature. The reaction was quenched with HCl (2 M, 20 mL). The organic phase was separated and the water phase was extracted with EtOAc (3×100 mL). The combined organic phase was washed with brine, dried and concentrated in vacuo. The product was used without further purification.

Workup

  1. additionwas added via a syringe
  2. stirringthe reaction mixture was stirred overnight at room temperature
  3. customThe reaction was quenched with HCl (2 M, 20 mL)
  4. customThe organic phase was separated
  5. extractionthe water phase was extracted with EtOAc (3×100 mL)
  6. washThe combined organic phase was washed with brine
  7. customdried
  8. concentrationconcentrated in vacuo
  9. customThe product was used without further purification

Sources & evidence

ORD record
ord-93d4d4b47c814b11852348a4b03cac92
Source dataset
uspto-grants-2013_01
Patent number
US08357710B2

Reaction notes

Loading…